The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial : The Lancet
Links shared publicly online about this topic.
- 479total visits
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial : The Lancet
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. By - Else Charlotte Sandset MD, Prof Philip MW Bath FRCP, P...
View full resource at thelancet.com
Tags: High Blood Pressure Medication, Stroke, Thrombotic Event, Atacand, Blopress
Most Recently Shared on March 12, 2011 at 10:36 pm By:
[Articles] The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, pla... http://bit.ly/hQyTP8
Advertisement
